Insight Molecular Diagnostics(DE:7OC0)
€2.08-0.14 (-6.31%)
DE:7OC0
Insight Molecular Diagnostics earnings date
€2.08
At close:-0.14 (-6.31%)
Insight Molecular Diagnostics (7OC0) Q2 2021 Earnings Report
1 Followers
DE:7OC0 Q2 2021 EPS Results
- Actual EPS
- -EUR 2.15
- Consensus EPS
- -EUR 1.80
- Beat/Miss
- Missed by -EUR 0.35
- One Year Ago EPS
- -EUR 2.51
DE:7OC0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 1.82M
- Expected Revenue
- EUR 1.41M
- Beat/Miss
- Beat by +EUR 408.28K
- YoY Revenue Growth
- +1319.58%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/10/2021
- Time
- After Close
- Conference Call
- Tuesday, August 10, 2021
DE:7OC0 Upcoming Earnings
Insight Molecular Diagnostics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7OC0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.21- | -0.3 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.23-0.28 | -0.27 | -3.33% (-0.01) | |
| May 13, 2026 | 2026 (Q1) | -0.23-0.11 | -0.23 | 53.85% (+0.13) | |
| Mar 26, 2026 | 2025 (Q4) | -0.21-0.64 | -1.73 | 62.69% (+1.08) | |
| Nov 10, 2025 | 2025 (Q3) | -0.19-0.30 | -0.36 | 15.42% (+0.06) | |
| Aug 11, 2025 | 2025 (Q2) | -0.21-0.27 | -0.34 | 22.08% (+0.08) | |
| May 12, 2025 | 2025 (Q1) | -0.21-0.23 | -0.55 | 57.93% (+0.32) | |
| Mar 24, 2025 | 2024 (Q4) | -0.36-1.73 | -2.03 | 14.98% (+0.30) | |
| Nov 12, 2024 | 2024 (Q3) | -0.39-0.36 | -0.73 | 50.37% (+0.37) | |
| Aug 08, 2024 | 2024 (Q2) | -0.50-0.34 | -0.96 | 64.02% (+0.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
